CD8A and COVID-19: The G2/M checkpoint pathway was upregulated in the CD8+ T cell group of COVID-19 patients (FDR < 0.003), a finding missed by the conventional analysis in Melms et al. (2021) but consistent with the expected increase in T cell proliferation in the lungs (Liao et al. 2020).